Litcius/Paper detail

PIKfyve inhibitors against SARS-CoV-2 and its variants including Omicron

Jingyi Su, Jing Zheng, Wei Huang, Yali Zhang, Cairui Lv, Baoding Zhang, Lina Jiang, Tong Cheng, Quan Yuan, Ningshao Xia, Jianming Zhang, Li Li, Li Li, Xianming Deng

2022Signal Transduction and Targeted Therapy18 citationsDOIOpen Access PDF

Topics & Concepts

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakVirologySars virusBetacoronavirusBiologyComputational biologyMedicinePathologyInfectious disease (medical specialty)DiseaseOutbreakCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchAdvanced Breast Cancer Therapies
PIKfyve inhibitors against SARS-CoV-2 and its variants including Omicron | Litcius